|
JPS59204036A
(ja)
|
1983-05-06 |
1984-11-19 |
Dainippon Ink & Chem Inc |
レジストパタ−ンの形成法
|
|
US5824311A
(en)
|
1987-11-30 |
1998-10-20 |
Trustees Of The University Of Pennsylvania |
Treatment of tumors with monoclonal antibodies against oncogene antigens
|
|
US4981784A
(en)
|
1987-12-02 |
1991-01-01 |
The Salk Institute For Biological Studies |
Retinoic acid receptor method
|
|
US5171671A
(en)
|
1987-12-02 |
1992-12-15 |
The Salk Institute For Biological Studies |
Retinoic acid receptor composition
|
|
US4870287A
(en)
|
1988-03-03 |
1989-09-26 |
Loma Linda University Medical Center |
Multi-station proton beam therapy system
|
|
US5906936A
(en)
|
1988-05-04 |
1999-05-25 |
Yeda Research And Development Co. Ltd. |
Endowing lymphocytes with antibody specificity
|
|
US5602009A
(en)
|
1988-12-23 |
1997-02-11 |
The Salk Institute For Biological Studies |
Dominant negative chimeras of the steroid/thyroid superfamily of receptors
|
|
US5164897A
(en)
|
1989-06-21 |
1992-11-17 |
Techpower, Inc. |
Automated method for selecting personnel matched to job criteria
|
|
ES2152920T3
(es)
|
1990-02-09 |
2001-02-16 |
Salk Inst For Biological Studi |
Composiciones receptoras de retinoides y metodos.
|
|
JPH06505152A
(ja)
|
1990-12-21 |
1994-06-16 |
ザ ロックフェラー ユニヴァーシティ |
肝集積性転写因子
|
|
US5851828A
(en)
|
1991-03-07 |
1998-12-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
US5912170A
(en)
|
1991-03-07 |
1999-06-15 |
The General Hospital Corporation |
Redirection of cellular immunity by protein-tyrosine kinase chimeras
|
|
US7049136B2
(en)
|
1991-03-07 |
2006-05-23 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
|
US5843728A
(en)
|
1991-03-07 |
1998-12-01 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
|
US6004811A
(en)
|
1991-03-07 |
1999-12-21 |
The Massachussetts General Hospital |
Redirection of cellular immunity by protein tyrosine kinase chimeras
|
|
US6887471B1
(en)
|
1991-06-27 |
2005-05-03 |
Bristol-Myers Squibb Company |
Method to inhibit T cell interactions with soluble B7
|
|
US6090914A
(en)
|
1991-06-27 |
2000-07-18 |
Bristol-Myers Squibb Company |
CTLA4/CD28Ig hybrid fusion proteins and uses thereof
|
|
US5851795A
(en)
|
1991-06-27 |
1998-12-22 |
Bristol-Myers Squibb Company |
Soluble CTLA4 molecules and uses thereof
|
|
DE59208378D1
(de)
|
1991-09-04 |
1997-05-28 |
Ciba Geigy Ag |
Verfahren zur Herstellung von Glykosiden
|
|
ATE215601T1
(de)
|
1991-09-17 |
2002-04-15 |
Salk Inst For Biological Studi |
Rezeptoren der steroid/thyroid superfamilie von rezeptoren
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
US6416998B1
(en)
|
1992-09-02 |
2002-07-09 |
Baylor College Of Medicine |
Plasmid encoding a modified steroid hormone
|
|
US5789187A
(en)
|
1992-08-27 |
1998-08-04 |
Worcester Foundation For Experimental Biology |
Identification of differentiation factor receptors which inhibit the tumorigenicity of neuroblastoma cells in a ligand-independent manner
|
|
US5846945A
(en)
|
1993-02-16 |
1998-12-08 |
Onyx Pharmaceuticals, Inc. |
Cytopathic viruses for therapy and prophylaxis of neoplasia
|
|
US5552303A
(en)
|
1993-03-08 |
1996-09-03 |
Immunex Corporation |
DNA encoding epithelium-derived T-cell factor
|
|
US5801005A
(en)
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
|
AU695869B2
(en)
|
1993-04-06 |
1998-08-27 |
Fred Hutchinson Cancer Research Center |
Chimeric cytokine receptors in lymphocytes
|
|
JPH08506247A
(ja)
|
1993-07-09 |
1996-07-09 |
アムジェン ボールダー インコーポレイテッド |
組換えｃｔｌａ４ポリペプチドおよびその製造方法
|
|
IL110298A
(en)
|
1993-07-13 |
1999-04-11 |
Brann Mark Robert |
Identification of ligands by selective amplification of cells transfected with receptors
|
|
GB9506466D0
(en)
|
1994-08-26 |
1995-05-17 |
Prolifix Ltd |
Cell cycle regulated repressor and dna element
|
|
AU685693B2
(en)
|
1994-11-01 |
1998-01-22 |
Targeted Genetics Corporation |
Chimeric receptors for the generation of selectively-activatable TH-independent cytotoxic T cells
|
|
US6005086A
(en)
|
1995-01-13 |
1999-12-21 |
The Salk Institute For Biological Studies |
Farnesoid activated receptor polypeptides, and nucleic acid encoding the same
|
|
US5935821A
(en)
|
1995-01-17 |
1999-08-10 |
Board Of Trustees Of The University Of Kentucky |
Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
|
|
US5712149A
(en)
|
1995-02-03 |
1998-01-27 |
Cell Genesys, Inc. |
Chimeric receptor molecules for delivery of co-stimulatory signals
|
|
US6103521A
(en)
|
1995-02-06 |
2000-08-15 |
Cell Genesys, Inc. |
Multispecific chimeric receptors
|
|
WO1996027392A1
(en)
|
1995-03-08 |
1996-09-12 |
The Scripps Research Institute |
Antigen presenting system and methods for activation of t-cells
|
|
US5763270A
(en)
|
1995-06-07 |
1998-06-09 |
Genemedicine, Inc. |
Plasmid for delivery of nucleic acids to cells and methods of use
|
|
WO1997005252A2
(en)
|
1995-07-26 |
1997-02-13 |
Nps Pharmaceuticals, Inc. |
Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US5750353A
(en)
|
1995-12-11 |
1998-05-12 |
New England Medical Center Hospitals, Inc. |
Assay for non-peptide agonists to peptide hormone receptors
|
|
US6084084A
(en)
|
1996-02-21 |
2000-07-04 |
Nps Pharmaceuticals, Inc. |
Human metabotropic glutamate receptor
|
|
US6451995B1
(en)
|
1996-03-20 |
2002-09-17 |
Sloan-Kettering Institute For Cancer Research |
Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
|
|
US5760395A
(en)
|
1996-04-18 |
1998-06-02 |
Universities Research Assoc., Inc. |
Method and apparatus for laser-controlled proton beam radiology
|
|
JP2001502521A
(ja)
|
1996-04-26 |
2001-02-27 |
ベス イスラエル デアコネス メディカル センター |
インターロイキン―１５の拮抗剤
|
|
US6451308B1
(en)
|
1996-04-26 |
2002-09-17 |
Beth Israel Deaconess Medical Center |
Antagonists of interleukin-15
|
|
IL126843A
(en)
|
1996-05-23 |
2007-06-17 |
Scripps Research Inst |
Mhc class ii antigen-presenting systems and methods for activating cd4+t cells in vitro
|
|
US5739169A
(en)
|
1996-05-31 |
1998-04-14 |
Procept, Incorporated |
Aromatic compounds for inhibiting immune response
|
|
US5844905A
(en)
|
1996-07-09 |
1998-12-01 |
International Business Machines Corporation |
Extensions to distributed MAC protocols with collision avoidance using RTS/CTS exchange
|
|
US7196164B2
(en)
|
1997-07-08 |
2007-03-27 |
Human Genome Sciences, Inc. |
Secreted protein HHTLF25
|
|
EP0970128A1
(en)
|
1997-03-21 |
2000-01-12 |
Brigham And Women's Hospital |
Immunotherapeutic ctla-4 binding peptides
|
|
US6120669A
(en)
|
1997-04-16 |
2000-09-19 |
Drexel University |
Bipolar electrochemical connection of materials
|
|
DE69834257T2
(de)
|
1997-04-30 |
2007-01-04 |
Klingemann, Hans |
Natürliche killerzelllinien und verfahren zu ihrer verwendung
|
|
JP2002513295A
(ja)
|
1997-07-08 |
2002-05-08 |
ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド |
１２３種類のヒト分泌タンパク質
|
|
US6416973B1
(en)
|
1997-08-01 |
2002-07-09 |
Schering Corporation |
Nucleic acids encoding mammalian cell membrane protein MDL-1
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
BR9907691B1
(pt)
|
1998-02-05 |
2011-05-31 |
|
derivado de antìgeno e antìgeno da famìlia mage associado a tumor, seqüência de ácido nucléico, codificando os mesmos, seus usos na preparação de vacina, processo para produção de vacina e vacina.
|
|
US6607879B1
(en)
|
1998-02-09 |
2003-08-19 |
Incyte Corporation |
Compositions for the detection of blood cell and immunological response gene expression
|
|
US7001733B1
(en)
|
1998-05-12 |
2006-02-21 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement
|
|
WO2000014257A1
(en)
|
1998-09-04 |
2000-03-16 |
Sloan-Kettering Institute For Cancer Research |
Fusion receptors specific for prostate-specific membrane antigen and uses thereof
|
|
AU2472400A
(en)
|
1998-10-20 |
2000-05-08 |
City Of Hope |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
|
|
ES2706547T3
(es)
|
1998-12-23 |
2019-03-29 |
Pfizer |
Anticuerpos monoclonales humanos para CTLA-4
|
|
US6307024B1
(en)
|
1999-03-09 |
2001-10-23 |
Zymogenetics, Inc. |
Cytokine zalpha11 Ligand
|
|
US6790662B1
(en)
|
1999-03-12 |
2004-09-14 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method of isolating CD8+ cells, and related hybridoma cells antibodies and polypeptides
|
|
JP2002541845A
(ja)
|
1999-04-16 |
2002-12-10 |
セルテック セラピューティックス リミテッド |
合成膜貫通成分
|
|
DK1187629T3
(da)
|
1999-04-19 |
2005-01-17 |
Glaxosmithkline Biolog Sa |
Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
|
|
US6747665B1
(en)
|
1999-05-10 |
2004-06-08 |
Ge Medical Systems Global Technology Company, Llc |
Semi-transparent medical image overlays
|
|
US6361714B1
(en)
|
1999-06-03 |
2002-03-26 |
Fuji Photo Film Co., Ltd. |
Method of preparing barium fluorohalide phosphor
|
|
US7605238B2
(en)
|
1999-08-24 |
2009-10-20 |
Medarex, Inc. |
Human CTLA-4 antibodies and their uses
|
|
NZ517202A
(en)
|
1999-08-24 |
2004-05-28 |
Medarex Inc |
Human CTLA-4 antibodies and their uses
|
|
US7118751B1
(en)
|
1999-10-14 |
2006-10-10 |
Trubion Pharmaceuticals, Inc. |
DNA vaccines encoding antigen linked to a domain that binds CD40
|
|
EP1284747A2
(en)
|
2000-05-12 |
2003-02-26 |
Beth Israel Deaconess Medical Center, Inc. |
Compositions and methods for achieving immune suppression
|
|
CA2410510A1
(en)
|
2000-06-02 |
2001-12-13 |
Memorial Sloan-Kettering Cancer Center |
Artificial antigen presenting cells and methods of use thereof
|
|
GB0017173D0
(en)
|
2000-07-12 |
2000-08-30 |
Bp Chem Int Ltd |
Process for the production of olefins
|
|
US7732133B2
(en)
|
2000-07-17 |
2010-06-08 |
Chugai Seiyaku Kabushiki Kaisha |
Screening methods for biologically active ligands
|
|
MXPA03002278A
(es)
|
2000-09-14 |
2004-12-03 |
Beth Israel Hospital |
Modulacion de respuestas de la celula t mediadas por il-2 e il-15.
|
|
GB0025307D0
(en)
|
2000-10-16 |
2000-11-29 |
Celltech Chiroscience Ltd |
Biological products
|
|
US20020102264A1
(en)
|
2000-10-18 |
2002-08-01 |
Cheung Nai-Kong V. |
Uses of monoclonal antibody 8H9
|
|
US6937446B2
(en)
|
2000-10-20 |
2005-08-30 |
Kabushiki Kaisha Toshiba |
Magnetoresistance effect element, magnetic head and magnetic recording and/or reproducing system
|
|
EP1356066A2
(en)
|
2000-10-24 |
2003-10-29 |
Syngenta Participations AG |
Control of gene expression in plants
|
|
US7446179B2
(en)
|
2000-11-07 |
2008-11-04 |
City Of Hope |
CD19-specific chimeric T cell receptor
|
|
US6706867B1
(en)
|
2000-12-19 |
2004-03-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
DNA array sequence selection
|
|
US20040071671A1
(en)
|
2001-02-20 |
2004-04-15 |
Leturcq Didier J. |
Cell therapy method for the treatment of tumors
|
|
DE60238308D1
(de)
|
2001-02-20 |
2010-12-30 |
Univ Georgia |
Schnellproduktion monoklonaler antikörper
|
|
US7723111B2
(en)
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
|
US7514537B2
(en)
|
2001-04-30 |
2009-04-07 |
City Of Hope |
Chimeric immunoreceptor useful in treating human gliomas
|
|
US6824974B2
(en)
|
2001-06-11 |
2004-11-30 |
Genorx, Inc. |
Electronic detection of biological molecules using thin layers
|
|
US20030211603A1
(en)
|
2001-08-14 |
2003-11-13 |
Earp David J. |
Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
|
|
US20030148982A1
(en)
|
2001-11-13 |
2003-08-07 |
Brenner Malcolm K. |
Bi-spcific chimeric T cells
|
|
JP3749873B2
(ja)
|
2002-03-28 |
2006-03-01 |
株式会社東芝 |
磁気抵抗効果素子、磁気ヘッド及び磁気再生装置
|
|
US8535672B2
(en)
|
2002-04-04 |
2013-09-17 |
Yissum Research Development Of The Hebrew University Of Jerusalem |
Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
|
|
DE60327199D1
(de)
|
2002-04-26 |
2009-05-28 |
Chugai Pharmaceutical Co Ltd |
Verfahren zum screening auf agonistische antikörper
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
US8263375B2
(en)
|
2002-12-20 |
2012-09-11 |
Acea Biosciences |
Dynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
|
|
WO2004028563A1
(en)
|
2002-09-27 |
2004-04-08 |
Genexine Inc. |
A vaccine enhancing the protective immunity to hepatitis c virus using plasmid dna and recombinant adenovirus
|
|
AU2003271904B2
(en)
|
2002-10-09 |
2009-03-05 |
Adaptimmune Limited |
Single chain recombinant T cell receptors
|
|
JP3836788B2
(ja)
|
2002-12-26 |
2006-10-25 |
株式会社東芝 |
磁気抵抗効果素子、磁気抵抗効果型ヘッドおよび磁気記録再生装置
|
|
CA2512110A1
(en)
|
2002-12-31 |
2004-07-22 |
Mmi Genomics, Inc. |
Compositions, methods, and systems for inferring bovine breed
|
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
US20050129671A1
(en)
|
2003-03-11 |
2005-06-16 |
City Of Hope |
Mammalian antigen-presenting T cells and bi-specific T cells
|
|
MXPA05014155A
(es)
|
2003-06-27 |
2006-05-25 |
Abgenix Inc |
Anticuerpos dirigidos a los mutantes de delecion de receptor de factor de crecimiento epidermico y sus usos.
|
|
US7527944B2
(en)
|
2003-06-27 |
2009-05-05 |
Monell Chemical Senses Center |
Taste receptors of the T1R family from domestic cat
|
|
AU2004257367A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Resverlogix, Inc. |
Compounds and methods for downregulating the effects of TGF-beta
|
|
JP4733635B2
(ja)
|
2003-07-31 |
2011-07-27 |
イミューノメディクス、インコーポレイテッド |
抗ｃｄ１９抗体
|
|
US7435596B2
(en)
|
2004-11-04 |
2008-10-14 |
St. Jude Children's Research Hospital, Inc. |
Modified cell line and method for expansion of NK cell
|
|
US20130266551A1
(en)
|
2003-11-05 |
2013-10-10 |
St. Jude Children's Research Hospital, Inc. |
Chimeric receptors with 4-1bb stimulatory signaling domain
|
|
US7682828B2
(en)
|
2003-11-26 |
2010-03-23 |
Whitehead Institute For Biomedical Research |
Methods for reprogramming somatic cells
|
|
US7089052B2
(en)
|
2004-02-26 |
2006-08-08 |
Tanita Corporation |
Method and system for estimating visceral fat area
|
|
EP2439284B1
(en)
|
2004-03-31 |
2019-05-08 |
The General Hospital Corporation |
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
|
|
AU2005256113B2
(en)
|
2004-07-09 |
2011-02-10 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-glypican 3 antibody
|
|
FR2873813B1
(fr)
|
2004-07-30 |
2006-11-17 |
Abx Sa |
Procede et dispositif de caracterisation des composants cellulaires d'un liquide biologique
|
|
CA2575490A1
(en)
|
2004-08-03 |
2006-02-16 |
Frank Notka |
Method for modulating gene expression by altering the cpg content
|
|
US7235190B1
(en)
|
2004-09-02 |
2007-06-26 |
Sandia Corporation |
Nanocluster-based white-light-emitting material employing surface tuning
|
|
BRPI0514641A
(pt)
|
2004-09-08 |
2008-06-17 |
Wisconsin Alumni Res Found |
cultivação das células tronco embriÈnica humana
|
|
PT1809321E
(pt)
|
2004-10-08 |
2012-05-17 |
Us Gov Health & Human Serv |
Imunoterapia adotiva com sobrevivência aumentada de linfócitos
|
|
US7485600B2
(en)
|
2004-11-17 |
2009-02-03 |
Honda Motor Co., Ltd. |
Catalyst for synthesis of carbon single-walled nanotubes
|
|
US7700728B2
(en)
|
2005-03-24 |
2010-04-20 |
Schering Corporation |
Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors
|
|
EP3530736A3
(en)
|
2005-05-09 |
2019-11-06 |
ONO Pharmaceutical Co., Ltd. |
Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
|
|
WO2007001677A2
(en)
|
2005-05-17 |
2007-01-04 |
University Of Connecticut |
Compositions and methods for immunomodulation in an organism
|
|
WO2006133398A2
(en)
|
2005-06-08 |
2006-12-14 |
Invitrogen Corporation |
In vitro activated donor t-cells to promote transplant engraftment
|
|
WO2007002905A1
(en)
|
2005-06-29 |
2007-01-04 |
University Of Miami |
Antibody-immune cell ligand fusion protein for cancer therapy
|
|
JP5299942B2
(ja)
|
2005-08-09 |
2013-09-25 |
オンコセラピー・サイエンス株式会社 |
ＨＬＡ−Ａ２陽性者用ｇｌｙｐｉｃａｎ−３（ＧＰＣ３）由来癌拒絶抗原ペプチド及びこれを含む医薬
|
|
US7341944B2
(en)
|
2005-09-15 |
2008-03-11 |
Honda Motor Co., Ltd |
Methods for synthesis of metal nanowires
|
|
EP1951751B1
(en)
|
2005-11-14 |
2017-11-01 |
Merial, Inc. |
Gene therapy for renal failure
|
|
WO2007067968A2
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
Effects of inhibitors of fgfr3 on gene transcription
|
|
US8129187B2
(en)
|
2005-12-13 |
2012-03-06 |
Kyoto University |
Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
|
|
US8278104B2
(en)
|
2005-12-13 |
2012-10-02 |
Kyoto University |
Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
|
|
EP2206724A1
(en)
|
2005-12-13 |
2010-07-14 |
Kyoto University |
Nuclear reprogramming factor
|
|
ATE533782T1
(de)
|
2006-01-13 |
2011-12-15 |
Univ Pennsylvania |
Impfstoffe und immuntherapeutika mit codon- optimiertem il-15 und verwendungsverfahren dafür
|
|
EP2366787B1
(en)
|
2006-01-13 |
2019-12-11 |
The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services |
Codon optimized IL-15 and IL-15R-Alpha genes for expression in mammalian cells
|
|
CA2643337C
(en)
|
2006-03-01 |
2016-01-12 |
Janssen Pharmaceutica N.V. |
Cancer treatment combining lymphodepleting agent with ctls and cytokines
|
|
EP2995950B1
(en)
|
2006-04-20 |
2024-01-17 |
Givaudan SA |
Method relating to sweetness enhancement
|
|
JP5300184B2
(ja)
|
2006-07-18 |
2013-09-25 |
キヤノン株式会社 |
圧電体、圧電体素子、圧電体素子を用いた液体吐出ヘッド及び液体吐出装置
|
|
US7972438B2
(en)
|
2006-08-30 |
2011-07-05 |
Crystal Photonics, Incorporated |
High-index UV optical materials for immersion lithography
|
|
US8323653B2
(en)
|
2006-09-08 |
2012-12-04 |
Medimmune, Llc |
Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
|
|
CN101548008B
(zh)
|
2006-10-04 |
2013-04-17 |
詹森药业有限公司 |
失活的人工抗原提呈细胞的制备及其在细胞疗法中的用途
|
|
US20100105136A1
(en)
|
2006-10-09 |
2010-04-29 |
The General Hospital Corporation |
Chimeric t-cell receptors and t-cells targeting egfrviii on tumors
|
|
WO2008060510A2
(en)
*
|
2006-11-13 |
2008-05-22 |
Sangamo Biosciences, Inc. |
Zinc finger nuclease for targeting the human glucocorticoid receptor locus
|
|
EP2114990B9
(en)
|
2007-02-27 |
2012-03-28 |
Nuclea Biomarkers LLC |
Method for predicting the response of NSCLC-patients to treatment by an EGFR-TK inhibitor
|
|
US8053615B2
(en)
|
2007-03-08 |
2011-11-08 |
Virent Energy Systems, Inc. |
Synthesis of liquid fuels and chemicals from oxygenated hydrocarbons
|
|
WO2008112886A1
(en)
|
2007-03-13 |
2008-09-18 |
Evident Technologies, Inc. |
Infrared display with luminescent quantum dots
|
|
DK3399025T3
(da)
|
2007-03-23 |
2025-06-16 |
Wisconsin Alumni Res Found |
Omprogrammering af somatiske celler
|
|
US8389282B2
(en)
|
2007-03-30 |
2013-03-05 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
|
|
WO2008127735A1
(en)
|
2007-04-13 |
2008-10-23 |
Stemline Therapeutics, Inc. |
Il3ralpha antibody conjugates and uses thereof
|
|
PT2170959E
(pt)
|
2007-06-18 |
2014-01-07 |
Merck Sharp & Dohme |
Anticorpos para o receptor humano de morte programada pd-1
|
|
EP2160404B1
(en)
|
2007-06-18 |
2016-08-24 |
Valorisation-Recherche, Limited Partnership |
Azapeptides as cd36 binding compounds
|
|
EP2173378B1
(en)
|
2007-06-27 |
2014-03-19 |
Admune Therapeutics LLC |
Complexes of il-15 and il-15ralpha and uses thereof
|
|
EP2048237A1
(en)
|
2007-10-05 |
2009-04-15 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Replication deficient Influenza virus for the expression of heterologous sequences
|
|
US20090017050A1
(en)
|
2007-07-13 |
2009-01-15 |
Ventana Medical Systems, Inc. |
Egfr antigen-binding molecules and uses thereof
|
|
US8900816B2
(en)
|
2007-07-19 |
2014-12-02 |
Duke University |
Assay for anti-EGFRvIII antibodies
|
|
CN101903403B
(zh)
|
2007-10-19 |
2016-03-16 |
西雅图基因公司 |
Cd19结合剂及其应用
|
|
US9683232B2
(en)
|
2007-12-10 |
2017-06-20 |
Kyoto University |
Efficient method for nuclear reprogramming
|
|
US8479118B2
(en)
|
2007-12-10 |
2013-07-02 |
Microsoft Corporation |
Switching search providers within a browser search box
|
|
PT2242773T
(pt)
|
2008-02-11 |
2017-09-15 |
Cure Tech Ltd |
Anticorpos monoclonais para o tratamento de tumores
|
|
US8168757B2
(en)
|
2008-03-12 |
2012-05-01 |
Merck Sharp & Dohme Corp. |
PD-1 binding proteins
|
|
JP5779090B2
(ja)
|
2008-04-09 |
2015-09-16 |
マックスサイト インコーポレーティッド |
新規に単離された細胞の治療組成物の操作および送達
|
|
US8591858B2
(en)
|
2008-05-01 |
2013-11-26 |
Honda Motor Co., Ltd. |
Effect of hydrocarbon and transport gas feedstock on efficiency and quality of grown single-walled nanotubes
|
|
JP5173594B2
(ja)
|
2008-05-27 |
2013-04-03 |
キヤノン株式会社 |
管理装置、画像形成装置及びそれらの処理方法
|
|
ES2587395T3
(es)
|
2008-06-04 |
2016-10-24 |
Cellular Dynamics International, Inc. |
Procedimientos para la producción de células IPS usando un enfoque no vírico
|
|
WO2010014784A2
(en)
|
2008-08-01 |
2010-02-04 |
Bristol-Myers Squibb Company |
Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
|
|
WO2010019569A1
(en)
|
2008-08-12 |
2010-02-18 |
Cellular Dynamics International. Inc. |
Methods for the production of ips cells
|
|
WO2010098788A2
(en)
|
2008-08-25 |
2010-09-02 |
Amplimmune, Inc. |
Pd-i antagonists and methods for treating infectious disease
|
|
CA2735456C
(en)
|
2008-08-26 |
2021-11-16 |
City Of Hope |
Method and compositions for enhanced anti-tumor effector functioning of t cells
|
|
MY153726A
(en)
|
2008-08-27 |
2015-03-13 |
Virent Inc |
Synthesis of liquid fuels from biomass
|
|
MX340972B
(es)
|
2008-10-08 |
2016-08-02 |
Intrexon Corp |
Celulas manipuladas por ingenieria que expresan multiples inmunomoduladores, y uso de las mismas.
|
|
WO2010042799A2
(en)
|
2008-10-09 |
2010-04-15 |
Howard Hughes Medical Institute |
Novel chimeric ligand-gated ion channels and methods of use thereof
|
|
EP3450545B1
(en)
|
2008-10-24 |
2023-08-23 |
Wisconsin Alumni Research Foundation |
Pluripotent stem cells obtained by non-viral reprogramming
|
|
CA2753158A1
(en)
|
2009-02-23 |
2010-08-26 |
Glenmark Pharmaceuticals S.A. |
Humanized antibodies that bind to cd19 and their uses
|
|
US8877199B2
(en)
|
2009-05-15 |
2014-11-04 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
B cell surface reactive antibodies
|
|
IT1394774B1
(it)
|
2009-06-04 |
2012-07-13 |
Univ Roma |
Costrutti esprimenti recettori chimerici, e loro uso per l'attivazione controllata delle risposte di difesa a organismi patogeni in piante
|
|
CN105925535A
(zh)
|
2009-06-05 |
2016-09-07 |
细胞动力国际有限公司 |
重编程t细胞和造血细胞的方法
|
|
US8900871B2
(en)
|
2009-08-07 |
2014-12-02 |
Kyoto University |
Method of producing induced pluripotent stem cells using inhibitors of P53
|
|
WO2011020047A1
(en)
|
2009-08-14 |
2011-02-17 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of il-15 to increase thymic output and to treat lymphopenia
|
|
US8889394B2
(en)
|
2009-09-07 |
2014-11-18 |
Empire Technology Development Llc |
Multiple domain proteins
|
|
JP5934099B2
(ja)
|
2009-10-01 |
2016-06-15 |
アメリカ合衆国 |
抗血管内皮増殖因子受容体−２キメラ抗原受容体及び癌の治療のためのその使用
|
|
US9273283B2
(en)
|
2009-10-29 |
2016-03-01 |
The Trustees Of Dartmouth College |
Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
|
|
WO2011059836A2
(en)
|
2009-10-29 |
2011-05-19 |
Trustees Of Dartmouth College |
T cell receptor-deficient t cell compositions
|
|
JP5956342B2
(ja)
|
2009-11-03 |
2016-07-27 |
シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ |
形質導入Ｔ細胞選択のためのトランケート上皮増殖因子レセプタ（ＥＧＦＲｔ）
|
|
KR101775926B1
(ko)
|
2009-11-04 |
2017-09-07 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
화학 물질을 이용한 에피솜 재프로그래밍
|
|
EP2504028A4
(en)
|
2009-11-24 |
2014-04-09 |
Amplimmune Inc |
SIMULTANEOUS INHIBITION OF PD-L1 / PD-L2
|
|
CN102753574B
(zh)
|
2009-12-11 |
2015-05-20 |
西马生物医学计划公司 |
用于免疫治疗和抗肿瘤治疗的缀合物和组合物
|
|
US9005967B2
(en)
|
2010-01-22 |
2015-04-14 |
Kyoto University |
Myc variants improve induced pluripotent stem cell generation efficiency
|
|
EP3053932B1
(en)
|
2010-02-19 |
2020-07-22 |
Xencor, Inc. |
Novel ctla4-ig immunoadhesins
|
|
CA2793753C
(en)
|
2010-03-26 |
2018-06-05 |
Memorial Sloan-Kettering Cancer Center |
Antibodies to muc16 and methods of use thereof
|
|
WO2011130491A2
(en)
|
2010-04-14 |
2011-10-20 |
Roger Williams Medical Center |
Methods and compositions for treating hiv
|
|
EP2566954B2
(en)
|
2010-05-04 |
2022-11-02 |
Yeda Research and Development Co. Ltd. |
Immunotherapy using redirected allogeneic cells
|
|
AU2011256838B2
(en)
|
2010-05-17 |
2014-10-09 |
Sangamo Therapeutics, Inc. |
Novel DNA-binding proteins and uses thereof
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
CA2802249A1
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
|
NZ603581A
(en)
|
2010-06-19 |
2015-05-29 |
Sloan Kettering Inst Cancer |
Anti-gd2 antibodies
|
|
WO2012012695A2
(en)
|
2010-07-23 |
2012-01-26 |
Fred Hutchinson Cancer Research Center |
A method for the treatment of obesity
|
|
WO2012136231A1
(en)
*
|
2010-09-08 |
2012-10-11 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Interleukin 15 as selectable marker for gene transfer in lymphocytes
|
|
EP2614143B1
(en)
|
2010-09-08 |
2018-11-07 |
Baylor College Of Medicine |
Immunotherapy of non-small lung cancer using genetically engineered gd2-specific t cells
|
|
EP3115373B1
(en)
|
2010-09-08 |
2019-08-28 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Chimeric antigen receptors with an optimized hinge region
|
|
US9845362B2
(en)
|
2010-10-08 |
2017-12-19 |
The University Of North Carolina At Charlotte |
Compositions comprising chimeric antigen receptors, T cells comprising the same, and methods of using the same
|
|
CN102443056B
(zh)
|
2010-10-15 |
2015-04-29 |
上海市肿瘤研究所 |
表皮生长因子受体的外显子缺失变异体
|
|
CA2817015A1
(en)
|
2010-11-09 |
2012-05-18 |
Altimab Therapeutics, Inc. |
Protein complexes for antigen binding and methods of use
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
JP5897035B2
(ja)
|
2010-12-14 |
2016-03-30 |
ユニバーシティ オブ メリーランド，ボルチモア |
汎用の抗タグキメラ抗原受容体発現ｔ細胞及びがんを治療する方法
|
|
US8642813B2
(en)
|
2010-12-30 |
2014-02-04 |
Virent, Inc. |
Reductive biomass liquefaction
|
|
JP2014509841A
(ja)
|
2011-01-18 |
2014-04-24 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
癌を治療するための組成物および方法
|
|
EA201401134A1
(ru)
|
2011-02-11 |
2015-05-29 |
Мемориал Слоан-Кеттеринг Кэнсер Сентер |
Hla-рестиктированные пептидоспецифические антигенсвязывающие белки
|
|
WO2012129514A1
(en)
|
2011-03-23 |
2012-09-27 |
Fred Hutchinson Cancer Research Center |
Method and compositions for cellular immunotherapy
|
|
EP3459560B1
(en)
|
2011-04-08 |
2021-02-24 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer
|
|
CN103502439B
(zh)
|
2011-04-13 |
2016-10-12 |
因缪尼卡姆股份公司 |
用于抗原特异性t细胞增殖的方法
|
|
US9206257B2
(en)
|
2011-04-19 |
2015-12-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies specific for glypican-3 and use thereof
|
|
US8398282B2
(en)
|
2011-05-12 |
2013-03-19 |
Delphi Technologies, Inc. |
Vehicle front lighting assembly and systems having a variable tint electrowetting element
|
|
US20130001376A1
(en)
|
2011-06-28 |
2013-01-03 |
F2M International Inc. |
Hose hanger
|
|
US9685295B2
(en)
|
2011-07-28 |
2017-06-20 |
The Board Of Trustees Of The University Of Illinois |
Electron emission device
|
|
KR102045349B1
(ko)
|
2011-08-16 |
2019-11-15 |
쇼오트 아게 |
형광체 조성물 및 그의 제조 방법
|
|
US9833476B2
(en)
|
2011-08-31 |
2017-12-05 |
The Trustees Of Dartmouth College |
NKP30 receptor targeted therapeutics
|
|
EP3692794A1
(en)
*
|
2011-09-16 |
2020-08-12 |
Baylor College of Medicine |
Targeting the tumor microenvironment using manipulated nkt cells
|
|
US9708384B2
(en)
|
2011-09-22 |
2017-07-18 |
The Trustees Of The University Of Pennsylvania |
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
|
|
JP6053688B2
(ja)
|
2011-10-07 |
2016-12-27 |
国立大学法人三重大学 |
キメラ抗原受容体
|
|
JP6267644B2
(ja)
|
2011-10-20 |
2018-01-24 |
アメリカ合衆国 |
抗ｃｄ２２キメラ抗原受容体
|
|
JP6074435B2
(ja)
|
2011-10-26 |
2017-02-01 |
ナショナル キャンサー センター |
変異ｃｔｌａ４遺伝子移入ｔ細胞及びこれを含む抗がん免疫治療用組成物
|
|
US9272002B2
(en)
|
2011-10-28 |
2016-03-01 |
The Trustees Of The University Of Pennsylvania |
Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
|
|
US9422351B2
(en)
|
2011-11-03 |
2016-08-23 |
The Trustees Of The University Of Pennsylvania |
Isolated B7-H4 specific compositions and methods of use thereof
|
|
WO2013070468A1
(en)
|
2011-11-08 |
2013-05-16 |
The Trustees Of The University Of Pennsylvania |
Glypican-3-specific antibody and uses thereof
|
|
WO2013071154A1
(en)
|
2011-11-11 |
2013-05-16 |
Fred Hutchinson Cancer Research Center |
Cyclin a1-targeted t-cell immunotherapy for cancer
|
|
US9422360B2
(en)
|
2011-12-19 |
2016-08-23 |
Zhonghao Chenguang Research Institute Of Chemical Industry Company Limited |
Porcine CD28 receptor, gene for encoding same, and application of same
|
|
AU2013216320A1
(en)
|
2012-02-01 |
2014-04-03 |
Compugen Ltd. |
C10RF32 antibodies, and uses thereof for treatment of cancer
|
|
EP2814846B1
(en)
|
2012-02-13 |
2020-01-08 |
Seattle Children's Hospital d/b/a Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
|
CA3285826A1
(en)
|
2012-02-22 |
2026-03-02 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer
|
|
BR112014020502A2
(pt)
|
2012-02-22 |
2019-09-24 |
Univ Pennsylvania |
sequência de ácido nucleico isolada, receptor quimérico de antígeno isolado, célula, vetor, e, métodos para estimular uma resposta imune, para fornecer uma imunidade antitumoral, para tratamento de um mamífero, para gerar e para expandir uma população de células - t, e para modular a quantidade de citocina secretada por uma célula -t
|
|
WO2013126726A1
(en)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Double transgenic t cells comprising a car and a tcr and their methods of use
|
|
EP2817330B1
(en)
|
2012-02-22 |
2020-07-08 |
The Trustees of the University of Pennsylvania |
Use of icos-based cars to enhance antitumor activity and car persistence
|
|
CA2868121C
(en)
|
2012-03-23 |
2021-06-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin chimeric antigen receptors
|
|
AU2013246443B2
(en)
|
2012-04-11 |
2017-04-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric antigen receptors targeting B-cell maturation antigen
|
|
US9156915B2
(en)
|
2012-04-26 |
2015-10-13 |
Thomas Jefferson University |
Anti-GCC antibody molecules
|
|
NZ702108A
(en)
|
2012-05-03 |
2016-09-30 |
Hutchinson Fred Cancer Res |
Enhanced affinity t cell receptors and methods for making the same
|
|
CN104395344B
(zh)
|
2012-05-07 |
2019-08-13 |
达特茅斯大学理事会 |
抗b7-h6抗体、融合蛋白及其使用方法
|
|
SG10201806573TA
(en)
*
|
2012-05-25 |
2018-09-27 |
Cellectis |
Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy
|
|
CA2875451A1
(en)
|
2012-06-08 |
2013-12-12 |
Kinki University |
Antibody against transporter and use thereof
|
|
KR20210149195A
(ko)
|
2012-07-13 |
2021-12-08 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
형질도입된 ｔ 세포의 투여 적합성을 평가하는 방법
|
|
JP2014022858A
(ja)
|
2012-07-17 |
2014-02-03 |
Murata Mfg Co Ltd |
電力増幅器
|
|
LT2884999T
(lt)
|
2012-08-20 |
2021-04-12 |
Fred Hutchinson Cancer Research Center |
Ląstelinės imunoterapijos būdas ir kompozicijos
|
|
WO2014055442A2
(en)
|
2012-10-01 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting stromal cells for the treatment of cancer
|
|
RU2729401C2
(ru)
|
2012-10-02 |
2020-08-06 |
Мемориал Слоан-Кеттеринг Кэнсер Сентер |
Композиции и способы для иммунотерапии
|
|
WO2014059173A2
(en)
|
2012-10-10 |
2014-04-17 |
Sangamo Biosciences, Inc. |
T cell modifying compounds and uses thereof
|
|
CN104822705B
(zh)
|
2012-10-24 |
2019-07-12 |
美国卫生和人力服务部 |
M971嵌合抗原受体
|
|
SG11201505858VA
(en)
|
2013-01-28 |
2015-09-29 |
St Jude Childrens Res Hospital |
A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
|
|
SG11201507026WA
(en)
|
2013-02-06 |
2015-10-29 |
Anthrogenesis Corp |
Modified t lymphocytes having improved specificity
|
|
JO3529B1
(ar)
|
2013-02-08 |
2020-07-05 |
Amgen Res Munich Gmbh |
مضاد التصاق خلايا الدم البيض من أجل التخفيف من الاثار السلبية الممكنة الناتجة عن مجالات ارتباط cd3- المحدد
|
|
IL305629A
(en)
|
2013-02-15 |
2023-11-01 |
Univ California |
Chimeric antigen receptor and methods of using it
|
|
SG11201505896YA
(en)
|
2013-02-20 |
2015-09-29 |
Novartis Ag |
Treatment of cancer using humanized anti-egfrviii chimeric antigen receptor
|
|
WO2014130635A1
(en)
|
2013-02-20 |
2014-08-28 |
Novartis Ag |
Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells
|
|
WO2014138314A1
(en)
|
2013-03-05 |
2014-09-12 |
Baylor College Of Medicine |
Oncolytic virus
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
ES2769574T3
(es)
|
2013-03-15 |
2020-06-26 |
Michael C Milone |
Reconocimiento de células citotóxicas con receptores quiméricos para inmunoterapia adoptiva
|
|
AU2014386824B2
(en)
*
|
2013-03-15 |
2019-05-09 |
Memorial Sloan-Kettering Cancer Center |
Compositions and methods for immunotherapy
|
|
US9657105B2
(en)
|
2013-03-15 |
2017-05-23 |
City Of Hope |
CD123-specific chimeric antigen receptor redirected T cells and methods of their use
|
|
US9393268B2
(en)
|
2013-03-15 |
2016-07-19 |
Thomas Jefferson University |
Cell-based anti-cancer compositions with reduced toxicity and methods of making and using the same
|
|
US9446105B2
(en)
|
2013-03-15 |
2016-09-20 |
The Trustees Of The University Of Pennsylvania |
Chimeric antigen receptor specific for folate receptor β
|
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
|
US9790282B2
(en)
|
2013-03-25 |
2017-10-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
|
|
CN104140974B
(zh)
|
2013-05-08 |
2017-09-29 |
科济生物医药（上海）有限公司 |
编码gpc‑3嵌合抗原受体蛋白的核酸及表达gpc‑3嵌合抗原受体蛋白的t淋巴细胞
|
|
EP2997134B1
(en)
*
|
2013-05-14 |
2020-06-24 |
Board of Regents, The University of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
CA2913052A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
JP6608807B2
(ja)
|
2013-05-29 |
2019-11-20 |
セレクティス |
Ｒｎａガイドｃａｓヌクレアーゼ系を用いることによって免疫療法のためにｔ細胞を操作するための方法
|
|
EP3569253A1
(en)
|
2013-06-05 |
2019-11-20 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
|
CA2912389C
(en)
|
2013-06-10 |
2020-01-28 |
The General Hospital Corporation D/B/A Massachusetts General Hospital |
Methods and compositions for reducing immunosupression by tumor cells
|
|
US9243068B2
(en)
|
2013-06-25 |
2016-01-26 |
Vaccinex, Inc. |
Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases
|
|
EP3027755B1
(en)
|
2013-08-02 |
2019-10-09 |
The Regents of The University of California |
Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors
|
|
CN105682683A
(zh)
|
2013-08-02 |
2016-06-15 |
阿杜罗生物科技控股有限公司 |
结合cd27激动剂以及免疫检查点抑制以用于免疫刺激
|
|
SMT202300039T1
(it)
|
2013-09-13 |
2023-03-17 |
Beigene Switzerland Gmbh |
Anticorpi anti-pd1 e loro uso come terapia e per diagnostica
|
|
US11807675B2
(en)
|
2013-10-03 |
2023-11-07 |
The University Of Maryland, Baltimore |
Nanoparticle based artificial antigen presenting cell mediated activation of NKT cells
|
|
EP3054987B1
(en)
|
2013-10-11 |
2019-10-09 |
The United States of America, represented by the Secretary, Department of Health and Human Services |
Tem8 antibodies and their use
|
|
AU2014337367B2
(en)
|
2013-10-15 |
2020-04-30 |
The Scripps Research Institute |
Peptidic chimeric antigen receptor T cell switches and uses thereof
|
|
EP3082802B1
(en)
|
2013-12-03 |
2020-02-26 |
Iomet Pharma Ltd. |
Tryptophan-2,3-dioxygenase (tdo) and/or indolamine-2,3-dioxygenase (ido) inhibitors and their use
|
|
SG10201804750XA
(en)
|
2013-12-06 |
2018-07-30 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through cd28
|
|
CA2977839C
(en)
|
2014-02-28 |
2022-07-26 |
The Royal Institution For The Advancement Of Learning / Mcgill University |
Tc-ptp inhibitors as apc activators for immunotherapy
|
|
CN122399016A
(zh)
|
2014-03-15 |
2026-07-17 |
诺华股份有限公司 |
使用嵌合抗原受体治疗癌症
|
|
TR201910814T4
(tr)
|
2014-03-19 |
2019-08-21 |
Cellectis |
Kanser immünoterapisi için cd123 spesifik kimerik antijen reseptörleri.
|
|
ES2765710T3
(es)
|
2014-04-03 |
2020-06-10 |
Cellectis |
Receptores de antígeno quimérico específicos de CD33 para la inmunoterapia del cáncer
|
|
WO2015188141A2
(en)
|
2014-06-06 |
2015-12-10 |
Memorial Sloan-Kettering Cancer Ceneter |
Mesothelin-targeted chimeric antigen receptors and uses thereof
|
|
US10550197B2
(en)
|
2014-06-18 |
2020-02-04 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
CAR-expressing NK-92 cells as cell therapeutic agents
|
|
JP6831777B2
(ja)
|
2014-07-21 |
2021-02-17 |
ノバルティス アーゲー |
Ｃｄ３３キメラ抗原受容体を使用する癌の処置
|
|
EP3177640B1
(en)
|
2014-08-08 |
2020-05-06 |
The Board of Trustees of the Leland Stanford Junior University |
High affinity pd-1 agents and methods of use
|
|
EP3712171A1
(en)
|
2014-08-19 |
2020-09-23 |
Novartis AG |
Treatment of cancer using a cd123 chimeric antigen receptor
|
|
DK3186284T3
(da)
|
2014-08-28 |
2022-05-09 |
Bioatla Inc |
Betinget aktive kimæriske antigenreceptorer til modificerede t-celler
|
|
ES2738705T3
(es)
|
2014-09-19 |
2020-01-24 |
Hope City |
Linfocitos T de receptor de antígeno quimérico coestimulante que se dirigen a IL13R 2
|
|
EP3206703B1
(en)
|
2014-10-14 |
2021-05-19 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Peptide for treating pancreatic cancer
|
|
EP3227317A4
(en)
|
2014-12-02 |
2018-04-25 |
Roger Williams Hospital |
Methods and compositons for treating cancer
|
|
HRP20240357T1
(hr)
|
2014-12-24 |
2024-06-07 |
Autolus Limited |
Stanica
|
|
EP3262166A4
(en)
|
2015-02-24 |
2018-08-15 |
The Regents of The University of California |
Binding-triggered transcriptional switches and methods of use thereof
|
|
CA2977106A1
(en)
|
2015-02-27 |
2016-09-01 |
Icell Gene Therapeutics Llc |
Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof
|
|
BR112017018770A2
(pt)
|
2015-03-02 |
2018-04-17 |
Innovative Cellular Therapeutics CO., LTD. |
redução da tolerância imunológica induzida por pd-l1
|
|
CN114456272A
(zh)
|
2015-04-03 |
2022-05-10 |
优瑞科生物技术公司 |
靶向afp肽/mhc复合体的构建体及其用途
|
|
PL3280729T3
(pl)
*
|
2015-04-08 |
2022-08-22 |
Novartis Ag |
Terapie cd20, terapie cd22 i terapie skojarzone komórką eksprymującą chimeryczny receptor antygenowy (car) cd19
|
|
MA41962A
(fr)
|
2015-04-23 |
2018-02-28 |
Baylor College Medicine |
Récepteur antigénique chimérique ciblant le cd5 pour une thérapie adoptive à base de cellules t
|
|
GB201507111D0
(en)
|
2015-04-27 |
2015-06-10 |
Ucl Business Plc |
Nucleic acid construct
|
|
EP3098237B1
(en)
|
2015-05-28 |
2018-08-01 |
Universität Zu Köln |
Anti-toso chimeric antigen receptor and its use
|
|
KR102349677B1
(ko)
|
2015-05-28 |
2022-01-12 |
카이트 파마 인코포레이티드 |
T 세포 요법을 위해 환자를 컨디셔닝하는 방법
|
|
WO2016197108A1
(en)
|
2015-06-05 |
2016-12-08 |
Board Of Regents, The University Of Texas System |
Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type
|
|
TWI833684B
(zh)
*
|
2015-06-25 |
2024-03-01 |
美商生物細胞基因治療有限公司 |
嵌合抗原受體（ｃａｒ）、組合物及其使用方法
|
|
CA2992122A1
(en)
|
2015-07-16 |
2017-01-19 |
Prospect CharterCare RWMC, LLC d/b/a Roger Williams Medical Center |
Compositions and methods for treating peritoneal cancers
|
|
EP4339287A3
(en)
*
|
2015-07-31 |
2024-05-22 |
Regents Of The University Of Minnesota |
Modified cells and methods of therapy
|
|
AU2016304060B2
(en)
|
2015-08-03 |
2022-09-29 |
Crage Medical Co., Limited |
Antibody against glypican-3 and application thereof
|
|
AU2016305087B2
(en)
*
|
2015-08-12 |
2022-01-20 |
Massachusetts Institute Of Technology |
Cell surface coupling of nanoparticles
|
|
CA2939288A1
(en)
|
2015-08-28 |
2017-02-28 |
Rolls-Royce High Temperature Composites, Inc. |
Ceramic matrix composite including silicon carbide fibers in a ceramic matrix comprising a max phase compound
|
|
EP3349791A1
(en)
|
2015-09-15 |
2018-07-25 |
Board of Regents, The University of Texas System |
T-cell receptor (tcr)-binding antibodies and uses thereof
|
|
ES2803728T3
(es)
|
2015-10-05 |
2021-01-29 |
Prec Biosciences Inc |
Células genéticamente modificadas que comprenden un gen de región constante alfa del receptor de linfocitos T humano modificado
|
|
WO2017075537A1
(en)
|
2015-10-30 |
2017-05-04 |
Aleta Biotherapeutics Inc. |
Compositions and methods for treatment of cancer
|
|
TWI724056B
(zh)
|
2015-11-19 |
2021-04-11 |
美商卡默森屈有限公司 |
Ｃｘｃｒ２抑制劑
|
|
TWI734715B
(zh)
|
2015-11-19 |
2021-08-01 |
美商卡默森屈有限公司 |
趨化因子受體調節劑
|
|
MX2018006789A
(es)
|
2015-12-03 |
2019-02-13 |
Juno Therapeutics Inc |
Receptores quimericos modificados y composiciones y metodos relacionados.
|
|
WO2017093969A1
(en)
*
|
2015-12-04 |
2017-06-08 |
Novartis Ag |
Compositions and methods for immunooncology
|
|
AU2016374497B2
(en)
|
2015-12-16 |
2022-03-10 |
The Walter And Eliza Hall Institute Of Medical Research |
Inhibition of cytokine-induced SH2 protein in NK cells
|
|
JP7012645B2
(ja)
|
2016-01-11 |
2022-01-28 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
キメラタンパク質および免疫治療の方法
|
|
WO2017123559A2
(en)
|
2016-01-11 |
2017-07-20 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric proteins and methods of regulating gene expression
|
|
CN113082201B
(zh)
|
2016-04-01 |
2024-07-05 |
上海斯丹赛生物技术有限公司 |
刺激t细胞介导的对表达抗原的细胞群的免疫应答的方法
|
|
IL263874B2
(en)
|
2016-06-22 |
2025-02-01 |
David Klatzmann |
Genetically modified T lymphocytes
|
|
CN109562126A
(zh)
*
|
2016-06-24 |
2019-04-02 |
美商生物细胞基因治疗有限公司 |
嵌合抗原受体(car)、组合物及其使用方法
|
|
EP3493827A4
(en)
|
2016-08-04 |
2020-02-26 |
Memorial Sloan-Kettering Cancer Center |
COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
|
|
EP3532075A4
(en)
|
2016-10-27 |
2020-07-08 |
Intima Bioscience, Inc. |
VIRAL METHODS OF MANUFACTURING GENETICALLY MODIFIED CELLS
|
|
SG11202010763VA
(en)
*
|
2018-05-03 |
2020-11-27 |
Univ Texas |
Natural killer cells engineered to express chimeric antigen receptors with immune checkpoint blockade
|